Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.

• Conditions: Achromobacter; Epidemiology; Chronic Ear Infection
• Interventions: Biological: Ear canal swab

• Registration Number: NCT04483232
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

Hearing loss can be the result of chronic ear infections. The role of bacteria of the genus Achromobacter is not known in these conditions. An epidemiological study including a large number of patients is needed to compare the prevalence of these bacteria in sick and healthy subjects, and to highlight the characteristics of the strains and the factors favouring their emergence.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-07
• Study First Submitted: 2020-07-17
• Study First Submitted QC: 2020-07-22
• Last Update Submitted: 2020-07-22
• Study First Posted: 2020-07-23
• Last Update Posted: 2020-07-23
• Study Start: 2020-08
• Primary Completion: 2020-08
• Study Completion: 2020-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1800

Inclusion Criteria

• Person or parent who has given his or her non-opposition
• Person over 10 years of age
• Sick Subjects Group :

diagnosis of chronic infection by an ENT specialist doctor if patient already included: new episode > 3 months after the complete clinical recovery from the previous episode observed by the ENT doctor - Healthy group: no ear infection in the last 6 months and no antibiotics in the previous month.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with ear infections	Ear canal swab	-
Healthy Subjects	Ear canal swab	-

Primary Outcome Measures

Name	Time	Method
Achromobacter positive sample number	Through study completion, an average of 3 years

Trial Locations

Locations (1)

Chu Dijon Bourgogne; 🇫🇷 Dijon, France